These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6364257)

  • 1. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Chmielewska J
    Przegl Lek; 1983; 40(8):619-22. PubMed ID: 6364257
    [No Abstract]   [Full Text] [Related]  

  • 2. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical assessment of electrolyte metabolism and the renin-aldosterone system in patients with liver cirrhosis and ascites].
    Mansurov KhKh; Dustov AD; Nikolaeva OS
    Ter Arkh; 1989; 61(11):54-7. PubMed ID: 2699096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver cirrhosis].
    Kato E; Nomoto Y
    Nihon Rinsho; 1971 Mar; 29(3):967-74. PubMed ID: 4324177
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver cirrhosis and the renin-angiotensin-aldosterone system].
    Lozano de León F; Leal M; Lissen E
    Rev Esp Enferm Apar Dig; 1986 Nov; 70(5):465-8. PubMed ID: 3797771
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of the renin-angiotensin-aldosterone system and urinary kallikrein in patients with ascitic hepatic cirrhosis].
    Aguglia F; Santucci A; De Mattia G; Gnecchi M; Trinchieri F; Giordano M; Cammarella I; Ficara C
    Clin Ter; 1983 Jul; 106(1):43-6. PubMed ID: 6556109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiotensin intradermoreaction in patients with liver cirrhosis in the ascitic phase. Results and interpretation in relation to the pathogenesis of the altered hydrosaline metabolism in cirrhogenic liver diseases].
    Santambrogio S; Natangelo R; Lucchelli PD
    Minerva Med; 1966 Dec; 57(101):4366-71. PubMed ID: 4289384
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin-aldosterone system in cirrhosis.
    Wilkinson SP; Williams R
    Gut; 1980 Jun; 21(6):545-54. PubMed ID: 7000629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin I converting enzyme].
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Trinchieri F; Giordano M; Gnecchi M; Ficara C
    Clin Ter; 1983 Jul; 106(2):121-4. PubMed ID: 6313280
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estimation of plasma renin, angiotensin II and urinary aldosterone in patients with cirrhosis of liver and its clinical significance].
    Tang ZD
    Zhonghua Nei Ke Za Zhi; 1982 Oct; 21(10):602-4. PubMed ID: 6759071
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our 2-year experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis with emphasis on the hemodynamic effects of the renin-angiotensin-aldosterone system].
    Cervinka J; Benes R; Kordac V; Horký K
    Cas Lek Cesk; 1984 Apr; 123(16):482-4. PubMed ID: 6733746
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis and treatment of the edema-ascites syndrome in patients with cirrhosis of the liver].
    Loginov AS; Berezov VM
    Ter Arkh; 1967 Aug; 39(8):12-20. PubMed ID: 4890954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renin angiotensin system and liver fibrosis or cirrhosis].
    Shen FJ; Yin CH; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):447-8. PubMed ID: 12890362
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of prostaglandins in hepatic cirrhosis with ascites].
    Pacheco D; Zamorano B; Feller A
    Rev Med Chil; 1986 Oct; 114(10):978-83. PubMed ID: 3575940
    [No Abstract]   [Full Text] [Related]  

  • 16. [The renin-angiotensin-aldosterone system in chronic diseases of the liver].
    Loginov AS; Khodarev NN; Astaf'eva OV
    Sov Med; 1988; (4):9-11. PubMed ID: 3043716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cirrhotic ascites and the renin-angiotensin system].
    Gonvers JJ; Loup P; Hofstetter JR; Brunner HR
    Schweiz Med Wochenschr; 1980 May; 110(22):869-71. PubMed ID: 6996085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretic treatment and renin-aldosterone axis in liver cirrhosis.
    Bernardi M; Trevisani F; De Palma R; Servadei D; Gasbarrini G
    Gastroenterology; 1984 Dec; 87(6):1405. PubMed ID: 6489706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effective blood volume and the renin-angiotensin-aldosterone system in cirrhosis].
    Decaux G
    Rev Med Brux; 1986 Apr; 7(4):211-2. PubMed ID: 3726336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.